Selected article for: "cell immunity and SARS vaccine"

Author: Edison Ong; Mei U Wong; Anthony Huffman; Yongqun He
Title: COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning
  • Document date: 2020_3_21
  • ID: ld0vo1rl_11
    Snippet: However, these predicted non-structural proteins (nasp3, 3CL-pro, nsp8, nsp9, and nsp10) 246 are not part of the viral structural particle, and all the current SARS/MERS/COVID-19 vaccine 247 studies target the structural (S/M/N) proteins. Although structural proteins are commonly used as 248 viral vaccine candidates, non-structural proteins correlates to vaccine protection. The non-249 structural protein NS1 was found to induce protective immunit.....
    Document: However, these predicted non-structural proteins (nasp3, 3CL-pro, nsp8, nsp9, and nsp10) 246 are not part of the viral structural particle, and all the current SARS/MERS/COVID-19 vaccine 247 studies target the structural (S/M/N) proteins. Although structural proteins are commonly used as 248 viral vaccine candidates, non-structural proteins correlates to vaccine protection. The non-249 structural protein NS1 was found to induce protective immunity against the infections by 250 flaviviruses 36 . Since NS1 is not part of the virion, antibodies against NS1 have no neutralizing 251 activity but some exhibit complement-fixing activity 37 . However, passive transfer of anti-NS1 252 antibody or immunization with NS1 conferred protection 38 . Anti-NS1 antibody could also reduce 253 might induce cell-mediated or humoral immunity necessary to prevent viral invasion and/or 262 replication. None of the non-structural proteins have been evaluated as vaccine candidates, and the 263 feasibilit of these proteins as vaccine targets are subject to further experimental verification. 264

    Search related documents:
    Co phrase search for related documents
    • anti ns1 antibody and protective immunity: 1
    • anti ns1 antibody and protein ns1: 1, 2
    • cell humoral mediate and protective immunity: 1
    • confer protection and infection protective immunity: 1, 2, 3, 4
    • confer protection and non structural protein: 1, 2
    • confer protection and passive transfer: 1, 2, 3, 4, 5
    • confer protection and protective immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • confer protection and protein ns1: 1, 2
    • confer protection and structural particle: 1
    • confer protection and structural protein: 1, 2, 3
    • confer protection and structural protein ns1: 1, 2
    • experimental verification and non structural protein: 1
    • experimental verification and structural protein: 1, 2
    • infection protective immunity and passive transfer: 1
    • infection protective immunity and protective immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • infection protective immunity and structural protein: 1, 2
    • infection protective immunity induce and protective immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • infection protective immunity induce and structural protein: 1
    • non structural protein and NS1 antibody: 1, 2, 3